Bruno Cenni

Title: Innovations by Bruno Cenni in Chronic Disease Treatment

Introduction

Bruno Cenni is a notable inventor based in Sissach, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of chronic diseases. With a total of 2 patents, his work focuses on innovative methods that enhance patient care and treatment outcomes.

Latest Patents

Cenni's latest patents include groundbreaking methods for treating chronic spontaneous urticaria and Sjögren's syndrome using Bruton's tyrosine kinase inhibitors. The first patent details methods for treating chronic spontaneous urticaria with a compound of Formula (I) or a pharmaceutically acceptable salt thereof. This patent also encompasses medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits designed for these treatments. The second patent addresses methods for treating Sjögren's syndrome, similarly utilizing a compound of Formula (I) or a pharmaceutically acceptable salt thereof, along with associated medicaments and treatment regimens.

Career Highlights

Bruno Cenni is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing innovative treatments that address unmet medical needs. His contributions have been instrumental in advancing therapeutic options for patients suffering from chronic conditions.

Collaborations

Cenni has collaborated with notable colleagues such as Souvik Bhattacharya and Bruno Bieth. These collaborations have fostered a productive environment for innovation and research, leading to the development of effective treatment methodologies.

Conclusion

Bruno Cenni's work exemplifies the impact of innovation in the medical field, particularly in the treatment of chronic diseases. His patents reflect a commitment to improving patient care through advanced therapeutic solutions.